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Background: The innate immune response plays an important role in the pathogenesis of intracerebral hemorrhage
(ICH). Recent studies have shown that Toll-like receptor 2 (TLR2) is involved in the innate immune response in various
neurological diseases, yet neither its role in ICH nor the mechanisms by which it functions have yet been elucidated.
We examined these in this study using a collagenase-induced mouse ICH model with TLR2 knock-out (KO) mice.
Results: TLR2 expression was upregulated in the ipsilateral hemorrhagic tissues of the collagenase-injected mice. Brain
injury volume and neurological deficits following ICH were reduced in TLR2 KO mice compared to wild-type (WT)
control mice. Heterologous blood-transfer experiments show that TLR2 signaling in brain-resident cells, but not leukocytes,
contributes to the injury. In our study to elucidate underlying mechanisms, we found that damage to blood–brain barrier
(BBB) integrity following ICH was attenuated in TLR2 KO mice compared to WT mice, which may be due to reduced
matrix metalloproteinase-9 (MMP9) activation in astrocytes. The reduced BBB damage accompanies decreased neutrophil
infiltration and proinflammatory gene expression in the injured brain parenchyma, which may account for the attenuated
brain damage in TLR2 KO mice after ICH.
Conclusions: TLR2 plays a detrimental role in ICH-induced brain damage by activating MMP9 in astrocytes,
compromising BBB, and enhancing neutrophils infiltration and proinflammatory gene expression.
Keywords: Toll-like receptor, Stroke, Neuroinflammation, Neutrophil, Matrix metalloproteinase-9Background
Intracerebral hemorrhage (ICH) is one of the major
types of stroke and accounts for 15% to 20% of all stroke
cases. In ICH, the initial insult by the mechanical force
of the expanding hematoma and plasma proteins is
usually followed by secondary damage, which involves
inflammatory responses in the perihematomal region
[1,2]. The inflammatory responses accompany activation
of brain-resident glial cells including microglia and
astrocytes, disruption of blood–brain barrier (BBB) and
subsequent edema, leukocyte recruitment to the injury* Correspondence: sjlee87@snu.ac.kr
†Equal contributors
1Department of Neuroscience and Physiology, and Dental Research Institute,
School of Dentistry, Seoul National University, Seoul 110-749, South Korea
Full list of author information is available at the end of the article
© 2015 Min et al.; licensee BioMed Central. Th
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.site, and induction of proinflammatory and potentially
neurotoxic mediators [3-7]. The concerted effects of these
inflammatory events result in massive neuronal death
leading to further sustained and aggravated neurological
damage subsequent to the stroke. It has been suggested
that hematoma release and its degradation products may
activate inflammatory responses at the perihematomal
region following ICH [8]. In addition, activation of
matrix metalloproteinases (MMPs) has been implicated in
the disruption of the BBB and perihematomal edema
formation [9-11]. However, the mechanisms underlying
the MMP activation and inflammatory responses following
ICH have not been clearly elucidated.
Toll-like receptor 2 (TLR2) is a type I transmembrane
receptor that recognizes lipoteichoic acid (LTA) andis is an Open Access article distributed under the terms of the Creative
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triggers inflammatory signals in innate immune cells.
Recent studies have shown that TLR2 functions as a
receptor not only for pathogen-associated molecular
patterns, but also for endogenous molecules released
from damaged tissues or cells, such as heat shock proteins
(HSPs) [12-14], hyaluronan [15], soluble CD14 [16] and
high mobility group box-1 (HMGB-1) [17,18]. Studies
suggest that TLR2 activation by these endogenous “danger
signals” is involved in the development of neuroinflamma-
tory responses in various neurological disorders [19,20].
For example, in traumatic brain injury, activation of
microglia and astrocytes in response to injury is
dependent on TLR2 signaling, which induces subsequent
proinflammatory gene expression around the lesion site of
a stab wound [21]. Likewise, TLR2 is required for nerve
injury-induced spinal cord microglia activation and
proinflammatory gene expression in the spinal cord
[22]. However, the function of TLR2 in ischemic brain
injury remains controversial. TLR2-deficient mice displayed
decreased brain injury and leukocyte infiltration compared
to wild-type (WT) mice, indicating a detrimental and pro-
inflammatory role of TLR2 in ischemic stroke [23,24].
However, in another study, TLR2 knock-out (KO)
mice showed higher mortality, decreased neurological
function, and increased brain infarct size [25], indicating a
neuroprotective role for TLR2. In line with a neuroprotec-
tive TLR2 role, upon spinal cord injury (SCI), locomotor
deficit is aggravated and recovery from injury is impaired
in TLR2-deficient mice [26]. Thus, in spinal cord injury,
TLR2-mediated innate immune responses seem to
facilitate recovery after injury. Despite these studies
implicating TLR2 in ischemic stroke, its role in ICH
has not been elucidated thus far. In this study, we
investigated the role of TLR2 in secondary inflammatory
brain damage following ICH using TLR2 KO mice in a
collagenase-induced ICH model.
Results
ICH-induced brain damage and neurologic deficits are
reduced in TLR2 KO mice
To test the involvement of TLR2 in ICH-type stroke, we
adopted a collagenase-induced ICH model, which is a
well-characterized animal model for ICH [27]. To begin
the study, we measured TLR2 expression in ICH-injured
mouse brain. After collagenase injection, TLR2 mRNA
(Figure 1A) and protein (Figure 1B-E) expression were
upregulated in WT mouse. To investigate the role of
TLR2 in ICH, we compared collagenase-induced ICH
injuries in WT and TLR2 KO mice brains. At 24 h
post-collagenase injection, severe hemorrhagic lesions
were detected in the stratum around the injection site
of the cresyl violet-stained brain sections from the WT
mice (Figure 1H). The lesion areas had slightly furtherincreased by 72 h post-injection (Figure 1J). In the TLR2
KO mice, the lesion areas were markedly smaller than in
the WT mice (Figure 1I and K). In both the WT and
TLR2 KO mice, no detectable hemorrhagic lesions
were observed in sham-operated mice (Figure 1F and G).
Quantification of injury volume confirmed that the
hemorrhagic volume was smaller in TLR2 KO mice than
in WT mice both at 24 h (10.5 vs. 6.3 mm3) and 72 h
(13.0 vs. 5.6 mm3) post-injection (Figure 1L).
ICH is usually accompanied by characteristic behavioral
deficits. To assess whether the reduced hemorrhagic
volumes in TLR2 KO mice manifested as reduced
neurological deficits, neurobehavioral tests were carried out
on the WT and TLR2 KO mice using a 28-point neuro-
logical scoring system [27]. At 24 and 72 h post-collagenase
injection, neurological scores were significantly lower in
TLR2 KO mice than in WT mice (12.5 vs 7.0 at 24 h, 11.0
vs 5.7 at 72 h) (Figure 2). These data demonstrate that both
post-hemorrhagic brain damage and neurological deficits
are reduced in the TLR2 KO mice.
Besides the collagenase-induced ICH model, ICH can
be mimicked by direct blood injection into the brain
parenchyma. This is another well-established ICH
animal model [28]. To test whether TLR2 is involved
in this ICH model as well, we measured the brain injury
volume in WT and TLR2 KO mice after autologous blood
injection (Figure 3). When compared to the WT mice, the
lesion volume of autologous blood-injected TLR2 KO
mice was reduced more than 85% (1.14 mm3 vs.
0.13 mm3), demonstrating that TLR2 contributes to ICH
damage in the blood-injection model as well. The injury
volume was also significantly reduced when the WT blood
was injected into the TLR2 KO mice, but not when TLR2
KO blood was injected into WT mice. These data suggest
that the effects observed in TLR2 KO mice were not due
to TLR2 deficiency in the brain-injected blood cells, rather
the effects were due to TLR2 deficiency in the resident
brain cells.
TLR2 signaling contributes to BBB damage after ICH
Collagenase injected into the brain parenchyma supposedly
induces hemorrhage by degrading extracellular matrix and
disrupting the BBB. To test if TLR2 is involved in BBB
damage due to collagenase injection, we intravenously
injected Evans blue dye into the ICH-damaged WT and
TLR2 KO mice and assessed BBB integrity by measuring
dye leakage into the brain parenchyma. In the ICH-
damaged mouse brain, Evans blue dye leakage was detected
around the lesion area boundary. In particular, TLR2
KO mice had smaller dye-stained areas than WT mice
(Figure 4A-H). Dye-stained volume in the TLR2 KO mice
brain was only 69% of that in WT mice (Figure 4I). In
both the WT and TLR2 KO mice, Evans blue dye leakage
was not detected in sham-control mice (data not shown).
Figure 1 ICH-induced brain injury volume is reduced in TLR2 KO mice. WT and TLR2 KO mice were treated with ICH by collagenase
injection (0.075 U in 0.5 μl PBS). (A) At 6 h following PBS or collagenase injection, total RNA was prepared from ipsilateral hemorrhagic tissue
in WT mice (n = 3) and used for quantitative real-time RT-PCR to measure TLR2 mRNA level. Data are expressed as mean ± SEM (*** p < 0.001,
vs. PBS-injected WT mice). (B-E) At 24 h after collagenase injection, the brains were sectioned and stained with TLR2 antibody. Scale bar: 50 μm.
WT and TLR2 KO mice (n = 5) were injected with either PBS (F and G) or collagenase (H-K), and the brains were sectioned and stained with
cresyl violet at 24 or 72 h following injection. Representative pictures are shown. Scale bar: 200 μm. (L) Injury volume (mm3) was calculated by
multiplying section thickness and injured hemorrhagic areas. Data are expressed as mean ± SEM (** p < 0.01, * p < 0.05, vs. collagenase-injected
WT mice, n = 5).
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severe BBB damage in TLR2 KO mice upon collagenase
injection.
TLR2 stimulation induces MMP9 activation in brain
astrocytes
Given that MMP9 is a key factor responsible for BBB
damage [10,29], we tested if TLR2-mediated signaling
affects gelatinase activity in ICH brains using in situzymography. Twelve hours post-injection, gelatinolytic
activity was observed in the ipsilateral perihematomal
regions of the WT mice (Figure 5A) indicating significant
activation of MMPs after ICH. Of note, ICH-induced gela-
tinolytic activity was much lower in TLR2 KO mice brains
than in those of WT mice (Figure 5B). To determine the
cellular sources of gelatinase activity, brain sections were
immunostained with cell type-specific antibodies. In
the perihematomal region of ICH-induced WT brains,
Figure 3 TLR2 expressed in brain parenchyma contributes to
ICH-induced brain damage. WT and TLR2 KO mice (n = 5) were
injected with either WT or TLR KO mouse blood (20 μl) in the
striatum: WT blood injection to WT mouse (WT→ WT) or to TLR2
KO mouse (WT→ KO). TLR2 KO blood injection to WT mouse (KO
→ WT) or to TLR2 KO mouse (KO→ KO). Saline (20 μl) was injected
to WT mouse (saline→ WT) or TLR2 KO mouse (saline→ KO) as
control. After 72 h, brain sections were prepared for cresyl violet
staining, and hemorrhagic injury volume was calculated. Data are
presented as mean ± SEM (** p < 0.01, * p < 0.05).
Figure 2 Neurological deficit after ICH is attenuated in TLR2 KO
mice. At 24 and 72 h following collagenase injection, neurological
deficits in WT (n = 5) and TLR2 KO (n = 5) mice were evaluated using
a 28-point neurological scoring system. Neurological scores of WT
and TLR2 KO mice before collagenase injection are presented as
control data (naïve). Data are presented as mean ± SEM (*** p < 0.001,
vs. collagenase-injected WT mice).
Min et al. Molecular Brain  (2015) 8:23 Page 4 of 14gelatinase activity was detected in GFAP-immunoreactive
(IR) astrocytes (Figure 5C). Outside the perihematomal
region (Figure 5E), gelatinase activity was localized to
NeuN-IR neurons (Figure 5D). However, no conspicuous
gelatinase activity was detected in CD11b-IR microglia or
CNPase-IR oligodendrocytes (data not shown). Since both
MMP2 and −9 confer gelatinase activity, we tested the
regulation of MMP2 and −9 gene expression. Following
an ICH, MMP9 transcript increased up to 10-fold in the
WT mice brains, whereas the induction level decreased by
48% in the TLR2 KO mice (Figure 5F). Meanwhile, the
ICH-induced MMP2 transcript level did not differ
between WTand TLR2 KO mice (Figure 5F). Comparably,
ICH induced MMP9 protein expression in WT mice
brains, which was not as significant in TLR2 KO mice
brains (Figure 5G-J). MMP9 expression was primarily
detected in GFAP-IR astrocytes (Figure 5K-M, arrows) and
not in CD68-IR macrophages/microglia (Figure 5N-P); this
suggests that ICH-induced MMP9 expression in astro-
cytes may have been responsible for the differential
gelatinolytic activity observed in brains of WT mice versus
TLR2 KO mice.
Since astrocytes are key components of the intact BBB,
it is conceivable that TLR2 activation on this cell type may
directly induce MMP9 activity and thereby compromise
the BBB in the perihematomal region. To address such a
possibility, we first tested TLR2 expression on astrocytes.
In primary cultured mixed glia from WT mouse cerebra,TLR2-IR was detected in a subpopulation of astrocytes
(Figure 6A-C, arrows). TLR2-IR was not detected in TLR2
KO astrocytes, demonstrating the specificity of the TLR2
antibody (Figure 6E). Activation of TLR2 on astrocytes by
Pam3, a synthetic TLR2 agonist, induced MMP9 enzym-
atic activity in the conditioned media, as measured by gel
zymography (Figure 6G), whereas the Pam3-induced
MMP9 activity was abrogated in astrocytes from TLR2
KO mice (Figure 6G), demonstrating the TLR2-dependent
activation of MMP9. We then tested MMP9 expression
in primary astrocytes. TLR2 stimulation induced MMP9
mRNA expression more than 5.8-fold in WT astro-
cytes, but it was almost completely blocked in TLR2 KO
astrocytes (Figure 6H). These data indicate that stimula-
tion of TLR2 on astrocytes induces MMP9 expression as
well as activity.
Neutrophil infiltration following ICH is attenuated in
TLR2 KO mice
Compromise of the BBB often results in immune cell
infiltration into brain parenchyma, which is implicated
in brain damage after collagenase-induced ICH [30]. To
test if TLR2-mediated BBB compromise affects immune
cell infiltration, we used flow cytometry to analyze brain
lesion-infiltrating immune cells (CD11b+/CD45hi) and
brain-resident microglia (CD11b+/CD45int) (Figure 7A).
The percentage of leukocytes (CD11b+/CD45hi) in brain
parenchyma 72 h after ICH increased from 2.1% to
Figure 4 TLR2 signaling contributes to collagenase-induced BBB
damage. (A-H) WT and TLR2 KO mice (n = 6) were injected with Evans
blue dye 2 days after ICH. ICH-injured brains were sectioned at 3 days,
and evaluated with either cresyl violet staining (A, C, E, and G) or
Evans blue staining under light microscope (B, D, F, and H). Serial
sections of two different brain regions were stained: AP, −0.85 (C, D, G,
and H) and AP, −0.45 (A, B, E, and F). Representative pictures are
shown. The Evans blue-stained brain volume was calculated and
presented in a graph (I). Data are expressed as mean ± SEM (* p < 0.05,
vs. collagenase-injected WT mice).
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the brain upon ICH, macrophages (CD11b+/CD45hi/Gr1low)
accounted for 2.6%, and neutrophils (CD11b+/CD45hi/Gr1hi)
1.7%, while the number of microglia (CD11b+/CD45int)
was not greatly altered (Figure 7B). In the ICH-induced
TLR2 KO brain parenchyma, comparable numbers of mac-
rophages and microglia were detected by flow cytometry
(Figure 7A and B). However, the percentage of brain-
infiltrating neutrophils in the TLR2 KO mice was reduced
by more than 50% compared to WT mice (Figure 7B). To
further confirm the putative correlation between BBB
damage and neutrophil infiltration in WT and TLR2
KO mice, we measured tissue-infiltrating neutrophils
by immunohistochemistry using antibodies against
Gr-1. Gr-1-IR neutrophils were detected at 24 h post-
injection, and the number was further increased at
72 h (Figure 7C and D). Compared to in WT mice,
Gr-1-IR neutrophils were markedly reduced in the
TLR2 KO mouse brain (Figure 7E and F). In both WTand
TLR2 KO mice, Gr-1-IR cells were rarely detected after
sham-operation (data not shown). Brain-infiltrating
neutrophils have been reported to inflict brain damage
[31,32] by producing reactive oxygen species (ROS) via
myeloid peroxidase (MPO) enzyme activity and TNF-α
production [33]. To test if these molecules are involved in
ICH-mediated brain damage, we quantified MPO activity
and TNF-α mRNA expression in the injured brain of WT
and TLR2 KO mice. At 24 h post-ICH, 510 U/g of MPO
activity was detected in the ipsilateral hemispheres of the
WT mice, whereas a decrease to 200 U/g was seen in
the TLR2 KO mice (Figure 7G). In addition, TNF-α
transcripts were upregulated 43-fold in the WT mice
upon ICH, while only a 23-fold increase was seen in
the TLR2 KO mice (Figure 7H). These data suggest a
possibility that attenuated production of ROS and
TNF-α in the TLR2 KO mice may have contributed
to the reduction of ICH damage in these mice.
Neutrophil-attracting chemokine and adhesion molecule
expression are attenuated in TLR2 KO mice
In our flow cytometry experiment, neutrophil infiltration,
but not macrophage infiltration, was affected in TLR2 KO
mice. This suggests that neutrophil-attracting mechanisms
Figure 5 (See legend on next page.)
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Figure 5 ICH-induced gelatinase activation is compromised in TLR2 KO mice. (A-B) At 24 h post-ICH, mice were sacrificed and cryosections
were incubated in fluorescein-conjugated DQ gelatin for 2 h. Fluorescence due to gelatinase activity in the perihematoma region was visualized
under fluorescent microscope. Scale bars: 50 μm. (C-D) Following in situ zymography, sections from WT mice were immunostained with anti-
GFAP (C) or NeuN (D) antibodies. The locations of the gelatinase activity shown in the panels C and D are denoted in panel E. Scale bars: 25 μm.
(F) At 6 h post-collagenase injection, total RNA was isolated from ipsilateral hemorrhagic tissue of WT and TLR2 KO mice (n = 4) and used to
measure MMP2 and MMP9 mRNA levels. Data are presented as mean ± SEM (** p < 0.01, vs. collagenase-injected WT mice). (G-J) Brain sections of
WT or TLR2 KO ICH mice (n = 3) were immunostained with anti-MMP9 antibody 24 h after collagenase injection. (K-P) ICH injured brain sections
obtained from WT or TLR2 KO mice were co-stained with anti-MMP9 and anti-GFAP (K-M) or anti-CD68 (N-P) antibodies to determine the cellular
source of MMP9. Scale bars: 50 μm.
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address the putative mechanism, the expression of the
neutrophil-attracting chemokines CXCL1 and CXCL2
in the injured brain tissue was measured by real-time
RT-PCR. The mRNA expression of CXCL1 and
CXCL2 was upregulated up to 300-fold in the WT
mouse brains at 6 h post-injection (Figure 8A); however,
the induction level of CXCL1 and CXCL2 was decreased
by 60% and 77%, respectively, in the TLR2 KO mice
compared to the WT mice (Figure 8A). The expression of
a monocyte-recruiting chemokine (CCL2) was also
upregulated (100-fold) in WT mice after ICH (Figure 8B).
However, the induction level of CCL2 was not signifi-
cantly decreased in TLR2 KO mice (Figure 8B). WeFigure 6 TLR2 signaling induces MMP9 activity in astrocytes. (A-F) Pri
were immunostained with anti-GFAP (A and D) and TLR2 (B and E) antibo
were prepared from WT and TLR2 KO mice and stimulated with Pam3 (2 μ
determined by gel zymography. (H) MMP9 transcript was determined by rea
Data are presented as mean ± SEM (* p < 0.01).also tested the expression of ICAM-1, as it has been
implicated in the recruitment of neutrophils from the
blood. Upon hemorrhagic injury, ICAM-1 transcript
was induced 40-fold in WT mice brains, whereas it
was upregulated only 13-fold in TLR2 KO mouse
brains (Figure 8C). In immunohistochemistry, CXCL1
and CXCL2 expressions were detected primarily in
GFAP-IR astrocytes within the peri-hematomal region
of WT mice (Figure 8D-F, J-L); however, the expres-
sion of both chemokines was significantly attenuated
in TLR2 KO mice (Figure 8G-I, M-O). These data suggest
that reduced CXCL1/2 and ICAM-1 expression may
result in reduced neutrophil infiltration in TLR2 KO
mice upon ICH.mary cerebral glia cultures prepared from WT and TLR2 KO mice
dies. Merged pictures are shown (C and F). (G) Primary astrocytes
g/ml). After 24 h, medium was collected and MMP9 activity was
l-time RT-PCR in primary astrocytes at 6 h after Pam3 stimulation.
Figure 7 Neutrophil infiltration following ICH is attenuated in TLR2 KO mice. (A-B) WT and TLR2 KO mice (n = 3) were subjected to
collagenase-induced ICH. After 24 h, brains were dissociated, and the percentages of leukocytes (Leu; CD45hi, CD11b+), macrophages (M; CD45hi,
CD11b+, Gr-1low), neutrophils (Neu; CD45hi, CD11b+, Gr-1hi), and microglia (Mg; CD45int, CD11b+) present in ICH-injured brain were determined by
flow cytometry. Data are presented as mean ± SEM (** p < 0.01, * p < 0.05). (C-F) At 24 h (C and E) and 72 h (D and F) following collagenase injection,
brain sections of WT and TLR2 KO mice (n = 5) were immunostained with anti-Gr-1 antibodies to detect neutrophil infiltration. Scale bars: 50 μm.
(G) MPO activity (U/g) was measured in the ipsilateral brain hemisphere of WT and TLR2 KO mice 24 h post-ICH. Data are expressed as mean ± SEM
(*** p < 0.001, vs. collagenase-injected WT mice, n = 5). (H) Total RNA was isolated from ipsilateral hemorrhagic tissue (AP, 0.0 to −2.0 mm) 6 h
post-ICH and used for quantitative real-time RT-PCR to measure TNF-α mRNA levels. Data are expressed as mean ± SEM (* p < 0.05, ** p < 0.01 vs.
collagenase-injected WT mice, n = 3).
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In this study, we have shown for the first time that TLR2
plays a detrimental role in brain damage due to ICH,
which was tested in two different ICH animal models:
collagenase-induced ICH and blood injection-mediated
ICH. Reductions in hemorrhagic volume, neurological
deficit, BBB compromise, neutrophil infiltration, and
inflammatory gene expression were observed in TLR2 KO
mice as compared to WT mice. Previous studies using an
ischemic brain injury model, such as MCAO, have shown
conflicting results as to the role of TLR2. While some
studies showed decreased brain injury in TLR2 KO mice
after a focal ischemia [23,24], another study showed
decreased neurological function and increased infarct size
in TLR2 KO mice, suggesting a neuroprotective effect of
TLR2 [25]. Our data are in line with the previous reports
showing neurotoxic effects of TLR2 in a MCAO strokemodel [23,24], yet the mechanisms of the detrimental
TLR2 effects in our ICH model are distinct from those in
the ischemic brain injury model.
In our study, we found that TLR2 contributes to
collagenase-induced BBB damage and MMP9 activation
in astrocytes in an ICH model. The critical role of
MMP9 in BBB damage has been well documented [10,29].
In the ischemic injury models, MMP9 activity was
detected in endothelial cells, astrocytes, and neurons
[34,35], and HMGB1 released during stroke was implicated
in activation of MMP9 via TLR4 signaling [36,37]. In our
study, the ICH-induced MMP9 activation in astrocytes was
dependent on TLR2. This implies that certain TLR2
endogenous agonist other than HMGB1 released during
ICH would activate MMP9 in astrocytes via TLR2 and
thereby exacerbate BBB damage. In addition, in an ische-
mic injury model, blockade of TLR2 signal by neutralizing
Figure 8 Neutrophil-attracting chemokine and adhesion molecule expression are attenuated in TLR2 KO mice.WT and TLR2 KO mice were
subjected to collagenase-induced ICH. Six h post-ICH, total RNA was isolated from ipsilateral hemorrhagic tissue (AP, 0.0 to −2.0 mm) and used for quantitative
real-time RT-PCR to measure CXCL1 and CXCL2 (A), CCL2 (B), and ICAM-1 (C)mRNA levels. Data are expressed as mean± SEM (** p< 0.01, * p< 0.05, vs.
collagenase-injected WT mice, n = 5). (D-O) Brain sections of WT (D-F, J-L) and TLR2 KO (G-I, M-O)mice (n = 3) were immunostained with anti-GFAP
(E, F, H, I, K, L, N, and O) and anti-CXCL1 (D, G, F, and I) or anti-CXCL2 (J, M, L, and O) antibodies 24 h after collagenase injection. Scale bars: 25 μm.
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brain parenchyma [38], suggesting a critical role in
brain damage for TLR2 expressed on macrophages,
not brain-resident glia. Furthermore, the absence of
TLR2 signaling did not affect neutrophil recruitment to
the infarct region in ischemic injury model [23]. However,
in the collagenase-induced ICH model, TLR2 expression
did not affect macrophage infiltration, rather it regulated
neutrophil infiltration. In addition, our data from
heterologous blood transfusion experiments show that
TLR2 KO mice are less susceptible to the blood
transfusion-induced brain damage compared to WT
mice, regardless of the genotype of the blood injected.
Although these data cannot be exactly extrapolated to
the collagenase-induced ICH, these data argue that
TLR2 expression in the cells of brain parenchyma
may play an important role in the detrimental effects
of TLR2. These data suggest that the pathogenic
mechanism of neuroinflammation following stroke is
quite distinct depending on the type of initial insult
(ischemia vs. hemorrhage).
In our study, MMP9 activity was detected in astrocytes,
but not in microglia. Still, considering TLR2 expression in
microglia, we do not exclude the possibility that TLR2
may also exert its proinflammatory and detrimental effects
by activating microglia independently of astrocyte MMP9
activation. It also must be noted that, in our in vivo data,
MMP9 was also expressed in neurons, yet we could not
detect TLR2 expression in neurons (data not shown). It
can be conjectured that neuronal MMP9 activation is
induced by inflammatory cytokines such as TNF-α
that are released during hemorrhage. Indeed, it has been
reported that MMP9 can be induced in TNF-α-stimulated
neuronal cells [39], and we found that TNF-α was induced
in the ICH-induced brain in a TLR2-dependent manner,
supporting this possibility.
In our study, we found that neutrophil infiltration after
ICH is reduced in TLR2 KO mice. Neutrophil infiltration
following ICH may cause tissue damage by generating
ROS and secreting proteases [40]. We found strong induc-
tion of MPO activity in the ICH-injured WT mice which
was ameliorated in the TLR2 KO mice. Oxidative stress by
MPO is implicated in neuronal cell death [41-43]. Reduced
neutrophil infiltration may therefore account for the
attenuation in ICH-induced damage volume observed in
TLR2 KO mice. Taken together, our data propose a novel
mechanism in secondary hemorrhagic brain injury in
which TLR2 activation on perihematomal astrocytes leads
to MMP9 activation and BBB disruption, which may
augment secondary brain damage following ICH. It implies
that the mechanisms of secondary neuroinflammatory
responses in hemorrhagic stroke are distinct from those in
ischemic stroke, and therefore should be clinically dealt
with in different fashions. In conclusion, we demonstratedin this study that TLR2 plays a detrimental role in
ICH-induced brain damage, at least partly by activating
MMP9 in astrocytes and recruiting neutrophils. This
suggests that TLR2 may be a novel therapeutic target
for treatment of ICH.
Conclusions
In this study, we revealed that TLR2 plays a detrimental
role in brain injury following ICH in a mouse model.
ICH-induced hemorrhagic lesion and neurological deficit
were significantly reduced in TLR2 KO mice. Similarly,
astrocyte MMP9 activation and subsequent BBB damage
after ICH were attenuated in TLR2 KO mice compared to
WT mice. The reduced BBB leakage in TLR2 KO mice
accompanied with attenuated neutrophil infiltration and
proinflammatory/neurotoxic gene expression, which may
account for the attenuated ICH damage in these mice.
Taken together, our data show that TLR2 contributes
to secondary inflammatory brain damage after ICH by




TLR2 KO mice [44] were generously provided by Dr. S.
Akira (Department of Host Defense, Osaka University,
Osaka, Japan). The TLR2 KO mice had been backcrossed
to the C57BL/6 background for more than 10 generations;
C57BL/6 mice purchased from Koatech (Pyeongtaek,
Korea) were used as WT control mice. The mice were
housed at 23 ± 2°C with a 12 h light–dark cycle and fed
food and water ad libitum. All surgical and experi-
mental procedures were reviewed and approved by
the Institutional Animal Care and Use Committee
(IACUC) at Seoul National University.
ICH model and hemorrhagic injury volume analysis
The procedure for inducing ICH by collagenase injection
in mice was carried out as described previously [45].
Briefly, WT and TLR2 KO mice (8–10 week old males,
22–25 g) were anesthetized using sodium pentobarbital
(30 mg/kg body weight, i.p.), and placed on a stereotaxic
apparatus (myNeuroLab, St. Louis, MO, USA). Animals
were injected with PBS or collagenase VII-S (0.075 U in
0.5 μl PBS; Sigma, St. Louis, MO, USA) at a rate of
0.5 μl/min into the right caudate putamen (stereotaxic
coordinates in mm with reference to bregma: AP, −1.0;
ML, −3.0; DV, −3.5) using a 26 G needle. In the ICH by
blood infusion model, mice were injected with blood
(20 μl) prepared from the tail vein at a rate of 1.5 μl/min.
Five min after the injection finished, the needle was
removed in three intermediate steps over 3 min in order
to minimize backflow. The incision was cleaned with
saline, sutured, and the animals were kept on a warm pad
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were deeply anesthetized with sodium pentobarbital and
perfused intracardially with saline followed by cold 4%
paraformaldehyde (PFA) in a 0.1 M phosphate buffer. The
brains were removed, post-fixed overnight in the same
fixative at 4°C, rinsed twice with PBS, and placed in 10,
20, and 30% sucrose in PBS, serially, for 48 h at 4°C. The
brains were then quickly frozen and cut into serial coronal
sections (50 μm thickness) in a cryostat (CM3050S, Leica,
Germany). Sections were collected as free-floating sec-
tions in cold PBS and then used for histochemical analysis.
Five coronal brain slices from different levels of the
injured hemorrhagic area were selected from each
mouse brain and used for cresyl violet staining. The
injury area was quantified using Imagepro Plus software
(Media Cybernetics, Inc., Rockville, MD, USA), and the
injury volume was calculated in cubic millimeters (mm3)
by multiplying the section thickness by the measured
injury areas as described elsewhere [46]. An experienced
experimenter blinded to the mouse genotypes ran the
Imagepro Plus software and performed the calculations
and analysis.
Primary glial cell culture
Primary mixed glial cultures were prepared as previously
described [47]. Briefly, mixed glial cultures were prepared
from postnatal day 1–3 WT or TLR2 KO mice. After
removing meninges from the cerebral hemisphere, tissue
was dissociated into a single-cell suspension by gentle
repetitive pipetting. Cells were cultured in DMEM
supplemented with 10 mM HEPES, 10% FBS, 2 mM
L-glutamine, and 1X antibiotic/antimycotic in 75 cm2
flasks at 37°C in a 5% CO2 incubator, and the medium
was changed every 5 days. After 2 weeks, microglia were
removed from culture by treating with 100 mM L-leucine
methyl ester for 60 min, then harvesting by trypsinization
(0.25% trypsin, 0.02% EDTA); cells were then seeded
in 6-well dishes or poly-D-lysine coated-glass slides,
depending on the experiment.
Evaluation of neurological deficit
Neurological deficits were assessed at 24 and 72 h
following collagenase injection. An experimenter blinded
to the mouse genotypes scored all mice for neurological
deficits using a 28-point neurological scoring system [27].
The tests included body symmetry, gait, climbing, circling
behavior, front limb symmetry, and compulsory circling.
Each test was graded from 0 to 4, establishing a maximum
deficit score of 28. The mice were sacrificed for analysis
immediately following testing.
Determination of BBB permeability
To evaluate BBB permeability, mice were intraperitoneally
(i.p.) injected with Evans blue dye (2% in saline, 4 ml/kg)at 2 days after collagenase injection. After 24 h, brain
tissues were harvested, fixed with 4% PFA, and placed in
30% sucrose in PBS for 48 h at 4°C. The brains were then
quickly frozen and cut into serial coronal sections (50 μm
thickness) in a cryostat. A single section was collected out
of every 8 consecutive sections, mounted on a slide, and
then visualized under a light microscope. The Evans blue
dye-stained area in each section was quantified using
Imagepro Plus software, summed throughout the injured
hemorrhagic brain area, and the total injury volume was
calculated in cubic millimeters (mm3) by multiplying the
section thickness by the measured area.
MPO activity assay
The extent of neutrophil infiltration was assessed by
measuring MPO activity as described previously [48,49].
In brief, mice were sacrificed with an overdose of sodium
pentobarbital 24 h after ICH, and transcardially perfused
with saline. Brains were extracted and dissected free of the
olfactory bulbs and the cerebellum. The ipsilateral
hemispheres were weighed and homogenized in a
20 mM phosphate buffer (pH 6.0) containing 0.5%
hexadecyltrimethyl ammonium bromide. Following
centrifugation at 18,000 xg for 30 min at 4°C, 0.1 ml of
supernatant was added to 0.6 ml of 0.1 M phosphate
buffer (pH 6.0) with 0.05% H2O2 containing 2 mg/ml
of o-dianisidine. After 10 min of incubation the reac-
tion was stopped by adding 0.1 ml of 1% NaN3, and
the rate of absorbance change was measured at 460 nm in
a spectrophotometer (BioRad, Hercules, CA, USA). MPO
activity was calculated using a standard curve prepared
with purified MPO (Sigma) and expressed as units per
gram (U/g) of tissue.
Real-time RT-PCR
Real-time RT-PCR was performed using SYBR Green
PCR Master Mix (ABI, Warrington, UK) as described
previously [50]. Reactions were performed in duplicate
in a total volume of 10 μl containing 10 pM primer, 4 μl
cDNA, and 5 μl SYBR Green PCR Master Mix. The
mRNA levels of each target gene were normalized to
that of GAPDH mRNA. Fold-induction was calculated
using the 2-ΔΔCT method, as previously described [51].
All real-time RT-PCR experiments were performed at
least three times, and are presented as mean ± SEM unless
otherwise noted. The following sequences of primers were
used for real-time RT-PCR: TLR2 forward: 5′-CCT AGA
AGT GGA AAA GAT GTC GTT CA-3′; TLR2 reverse:
5′-GAA GAA AAC GGA ATT CTC TTT TCG AC-3′;
TNF-α forward: 5′-AGC AAA CCA CCA AGT GGA
GGA-3′; TNF-α reverse: 5′-GCT GGC ACC ACT AGT
TGG TTG T-3′; CXCL1 forward: 5′-CCG AAG TCA
TAG CCA CAC TCA A-3′; CXCL1 reverse: 5′-GCA
GTC TGT CTT CTT TCT CCG TTA C-3′; CXCL2
Min et al. Molecular Brain  (2015) 8:23 Page 12 of 14forward: 5′-AGA CAG AAG TCA TAG CCA CTC TCA
AG-3′; CXCL2 reverse: 5′-CCT CCT TTC CAG GTC
AGT TAG C-3′; CCL2 forward: 5′-TCA GCC AGA TGC
AGT TAA CG-3′; CCL2 reverse: 5′-GAT CCT CTT GTA
GCT CTC CAG C-3′; ICAM-1 forward: 5′-GAT CAC
ATT CAC GGT GCT GG-3′; ICAM-1 reverse: 5′-GAG
AAA TTG GCT CCG TGG TC-3′; MMP-9 forward:
5′-CAT TCG CGT GGA TAA GGA GT-3′; MMP-9
reverse: 5′-ACC TGG TTC ACC TCA TGG TC-3′;
GAPDH forward: 5′-CAC CCT GTT GCT GTA GCC
GTA T-3′; GAPDH reverse: 5′-AGG TCA TCC CAG
AGC TGA ACG-3′.
Immunofluorescence staining
Immunostaining was carried out using previously estab-
lished procedures [50]. The sections were incubated in a
blocking solution (5% normal donkey serum, 2% BSA, and
0.1% Triton X-100) for 1 h at room temperature (RT).
The sections were then incubated overnight at 4°C with
the following antibodies: mouse anti- TLR2 (1:200;
eBioscience, San Diego, CA, USA), mouse anti-NeuN
(1:2,000; Millipore, Billerica, MA, USA), rabbit anti-GFAP
(1:10,000; DAKO, Denmark), rat anti-CD68 (1:1000; AbD
Serotec, Raleigh, NC, USA), mouse anti-MMP9 (1:500;
abcam, UK), rat anti-Gr-1 (1:1,000; Invitrogen, Carlsbad,
CA, USA) goat anti-CXCL1 (1:100; Santa Cruz, Dallas,
TX, USA), goat anti-CXCL2 (1:100; Santa Cruz). The
sections were incubated for 1 h at RT with FITC- or
Cy3-conjugated secondary antibodies (1:200; Jackson
ImmunoResearch, West Grove, PA, USA), and then
mounted on gelatin-coated slides and coverslipped with
VectaShield medium (Vector Labs, Burlingame, CA,
USA). Images were captured using confocal laser scanning
microscopy (LSM5 PASCAL; Carl Zeiss, Germany).
Gel zymography
Cells were incubated with or without 2 μg/ml of Pam3
in serum-free media at 37°C in a 5% CO2 incubator for
24 h and supernatants were collected. To concentrate
protein, 3 volumes of ethanol was added to supernatant,
and the mixture was incubated at −20°C for 1 h and
centrifuged at 18,000 xg for 30 min at 4°C. Precipitates
were resuspended in sample buffer (0.25 M tris pH 6.8,
10% glycerol, 2% SDS) and subjected to SDS-PAGE in
8% polyacrylamide gels containing 1 mg/ml gelatin.
After electrophoresis, gels were incubated with 2.5%
Triton X-100 for 30 min at RT and incubated with
zymography developing buffer for 30 h at 37°C. The
gels were stained with 0.25% Coomassie blue and
destained to visualize MMP9 activity.
In situ zymography
In situ gelatinolytic activity was measured on frozen
sections (16 μm thickness) as described previously [30].At 24 h following ICH, brains were removed and immedi-
ately frozen on dry ice. Fresh sections were incubated with
fluorescein-conjugated DQ gelatin substrate (Invitrogen)
for 2 h and fixed and mounted with VectaShield medium.
Cleavage of DQ gelatin by MMPs results in green
fluorescent products. After gelatinolytic activity had
been assessed, some sections were fixed with 4% PFA and
incubated with primary antibodies specific to neurons
(NeuN) or astrocytes (GFAP; Millipore), followed by
Cy3-conjugated secondary antibodies. Images were then
captured using confocal laser scanning microscopy.
Flow cytometry
To measure inflammatory cell infiltration in the brain,
flow cytometry was performed. Single cell suspensions
were prepared from ipsilateral hemispheres 72 h after
ICH, washed with 2% fetal bovine serum in PBS, and
incubated with Fc blocker™ (BD Biosciences, San Jose,
CA) for 10 min at 4°C. After washing twice with 2% FBS
in PBS, cells were incubated with PE-conjugated CD45,
APC-conjugated CD11b, and FITC-conjugated GR-1
antibodies (BD Biosciences) for 30 min at 4°C. A BD
FACSCalibur flow cytometer (BD Biosciences) was used
to measure microglia (CD45int, CD11b+, Gr-1−), leukocyte
(CD45hi), macrophage (CD45hi, CD11b+, Gr-1−), and
neutrophil (CD45hi, CD11b+, Gr-1+) populations as defined
elsewhere [52,53]. Data were collected and analyzed using
the BD CellQuest™ System (BD Biosciences).
Statistical analysis
Statistically significant differences between the WT and
TLR2 KO mice were determined by paired Student’s
t-test or one-way ANOVA with Tukey’s multiple compari-
son test. All data are presented as the mean ± SEM, and
differences were considered significant when the p value
was less than 0.05.
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